PM vs REGN · P/E 28, rev $40.65B vs P/E 14, rev $14.34B
Philip Morris International Inc (PM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Philip Morris International Inc (PM) is a tobacco company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PM revenue for 2025-12-31 was $40.65B. Net income was $11.35B. Revenue was up 7.3% from 2024-12-31 to 2025-12-31. PM currently screens at market cap $278.43B and trailing P/E 28.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PM currently screens at market cap $278.43B and trailing P/E 28.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PM and REGN stock pages for the full models.
Not investment advice.